These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 9326297)

  • 1. 3-Methoxytyramine formation following monoamine oxidase inhibition is a poor index of dendritic dopamine release in the substantia nigra.
    Elverfors A; Pileblad E; Lagerkvist S; Bergquist F; Jonason J; Nissbrandt H
    J Neurochem; 1997 Oct; 69(4):1684-92. PubMed ID: 9326297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reserpine-insensitive dopamine release in the substantia nigra?
    Elverfors A; Nissbrandt H
    Brain Res; 1991 Aug; 557(1-2):5-12. PubMed ID: 1720998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of d-amphetamine on dopaminergic neurotransmission; a comparison between the substantia nigra and the striatum.
    Elverfors A; Nissbrandt H
    Neuropharmacology; 1992 Jul; 31(7):661-70. PubMed ID: 1328918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and release of dopamine in rat brain: comparison between substantia nigra pars compacts, pars reticulata, and striatum.
    Nissbrandt H; Sundström E; Jonsson G; Hjorth S; Carlsson A
    J Neurochem; 1989 Apr; 52(4):1170-82. PubMed ID: 2564423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemistry of somatodendritic dopamine release in substantia nigra: an in vivo comparison with striatal dopamine release.
    Heeringa MJ; Abercrombie ED
    J Neurochem; 1995 Jul; 65(1):192-200. PubMed ID: 7790860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minor effect of tolcapone, a catechol-O-methyltransferase inhibitor, on extracellular dopamine levels modified by amphetamine or pargyline: a microdialysis study in anaesthetized rats.
    Tuomainen P; Törnwall M; Männistö PT
    Pharmacol Toxicol; 1996 Jun; 78(6):392-6. PubMed ID: 8829199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Turnover of dopamine and dopamine metabolites in rat brain: comparison between striatum and substantia nigra.
    Nissbrandt H; Carlsson A
    J Neurochem; 1987 Sep; 49(3):959-67. PubMed ID: 3612134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of monoamine oxidase inhibition on the release of 3H-dopamine elicited by potassium and by amphetamine from the rat substantia nigra and corpus striatum.
    Arbilla S; Langer SZ
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Feb; 311(1):45-52. PubMed ID: 7366741
    [No Abstract]   [Full Text] [Related]  

  • 9. Microdialysis with radiometric monitoring of L-[β-11C]DOPA to assess dopaminergic metabolism: effect of inhibitors of L-amino acid decarboxylase, monoamine oxidase, and catechol-O-methyltransferase on rat striatal dialysate.
    Okada M; Nakao R; Hosoi R; Zhang MR; Fukumura T; Suzuki K; Inoue O
    J Cereb Blood Flow Metab; 2011 Jan; 31(1):124-31. PubMed ID: 20407462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does monoamine oxidase inhibition by pargyline increase extracellular dopamine concentrations in the striatum?
    Blaha CD; Coury A; Phillips AG
    Neuroscience; 1996 Nov; 75(2):543-50. PubMed ID: 8931017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a short period of vitamin E-deficient diet in the turnover of different neurotransmitters in substantia nigra and striatum of the rat.
    Castaño A; Herrera AJ; Cano J; Machado A
    Neuroscience; 1993 Mar; 53(1):179-85. PubMed ID: 7682297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoflurane anesthesia induces biphasic effect on dopamine release in the rat striatum.
    Adachi YU; Yamada S; Satomoto M; Higuchi H; Watanabe K; Kazama T
    Brain Res Bull; 2005 Oct; 67(3):176-81. PubMed ID: 16144652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dopamine agonists and antagonists on DOPA formation in the substantia nigra.
    Argiolas A; Melis MR; Fadda F; Serra G; Gessa GL
    J Neurochem; 1982 Jan; 38(1):75-9. PubMed ID: 6809898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of dopamine release in the substantia nigra by in vivo microdialysis in freely moving rats.
    Robertson GS; Damsma G; Fibiger HC
    J Neurosci; 1991 Jul; 11(7):2209-16. PubMed ID: 1712381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of R-type (Cav2.3) and t-type (Cav3.1-3.3) antagonists on nigral somatodendritic dopamine release measured by microdialysis.
    Bergquist F; Nissbrandt H
    Neuroscience; 2003; 120(3):757-64. PubMed ID: 12895515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age effects on monoamine turnover of the rat substantia nigra.
    Venero JL; Machado A; Cano J
    Brain Res; 1991 Aug; 557(1-2):109-14. PubMed ID: 1747745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenylalanine in the caudate nucleus of dopamine depleted rats.
    Paetsch PR; Greenshaw AJ; Juorio AV
    Neurochem Res; 1993 Sep; 18(9):983-7. PubMed ID: 7694165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoamine oxidase-dependent metabolism of dopamine in the striatum and substantia nigra of L-DOPA-treated monkeys.
    Di Monte DA; DeLanney LE; Irwin I; Royland JE; Chan P; Jakowec MW; Langston JW
    Brain Res; 1996 Oct; 738(1):53-9. PubMed ID: 8949927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of GBR 12909, a dopamine re-uptake inhibitor, on monoaminergic neurotransmission in rat striatum, limbic forebrain, cortical hemispheres and substantia nigra.
    Nissbrandt H; Engberg G; Pileblad E
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):16-28. PubMed ID: 1663587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lesion-induced reductions in trace amine accumulation: dependence on MAO inhibitor pretreatment.
    Nguyen TV; Juorio AV; Greenshaw AJ
    Brain Res Bull; 1989 Feb; 22(2):197-200. PubMed ID: 2495844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.